4.7 Letter

Reply to M. Baboudjian et al

Related references

Note: Only part of the references are listed.
Editorial Material Oncology

Low-Grade Prostate Cancer: Time to Stop Calling It Cancer comment

Scott E. Eggener et al.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Multidisciplinary Sciences

Impact of active surveillance for prostate cancer on the risk of depression and anxiety

Davidson Sypre et al.

Summary: Active surveillance is a standard treatment option for low risk localized prostate cancer. This study found that patients managed with active surveillance do not report more anxiety or depressive symptoms compared to patients managed with curative treatment.

SCIENTIFIC REPORTS (2022)

Article Medicine, General & Internal

MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis

Michael Ahdoot et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)